Lv41
518 积分 2024-12-10 加入
Immunotherapy checkpoints in ovarian cancer vasculogenic mimicry: Tumor immune microenvironments, and drugs
2个月前
已完结
The Emerging Role of the Single-Cell and Spatial Tumor Microenvironment in High-Grade Serous Ovarian Cancer
2个月前
已完结
T cell exhaustion and senescence for ovarian cancer immunotherapy
2个月前
已完结
Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment
2个月前
已完结
Ovarian cancer-derived IL-4 promotes immunotherapy resistance
2个月前
已完结
Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions
7个月前
已完结
Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review
7个月前
已完结
Controversies in the Management of Clear Cell Carcinoma of the Uterus and Ovary
7个月前
已完结
Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype
9个月前
已完结
Probability of detecting germline BRCA1/2 pathogenic variants in histological subtypes of ovarian carcinoma. A meta-analysis
9个月前
已完结
皖公网安备34019202002308
